Pakalpojumi - 421567-2021

20/08/2021    S161

Belgium-Brussels: Feasibility Study, Design and Prototype Development for a Mapping Platform on COVID-19 Therapeutics in the EU

2021/S 161-421567

Corrigendum

Notice for changes or additional information

Services

(Supplement to the Official Journal of the European Union, 2021/S 156-410635)

Legal Basis:
Regulation (EU, Euratom) No 2018/1046

Section I: Contracting authority/entity

I.1)Name and addresses
Official name: European Health and Digital Executive Agency (HaDEA), HADEA.A - Health and Food
Postal address: COV2, Place Charles Rogier 16
Town: Brussels
NUTS code: BE100 Arr. de Bruxelles-Capitale / Arr. Brussel-Hoofdstad
Postal code: B-1210
Country: Belgium
E-mail: HADEA-HP-TENDER@ec.europa.eu
Internet address(es):
Main address: https://hadea.ec.europa.eu

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Feasibility Study, Design and Prototype Development for a Mapping Platform on COVID-19 Therapeutics in the EU

Reference number: HADEA/2021/OP/0009-PIN
II.1.2)Main CPV code
73000000 Research and development services and related consultancy services
II.1.3)Type of contract
Services
II.1.4)Short description:

Service contract encompassing the feasibility assessment, the design and prototype development of an interactive platform mapping the production capacity and supply of COVID-19 therapeutics in the EU including products in research and development phases. Such therapeutics can include ICU medicines, heparin, dexamethasone and antibiotics, in vitro diagnostics devices/companion diagnostics.

Section VI: Complementary information

VI.5)Date of dispatch of this notice:
17/08/2021
VI.6)Original notice reference
Notice number in the OJ S: 2021/S 156-410635

Section VII: Changes

VII.1)Information to be changed or added
VII.1.2)Text to be corrected in the original notice
Section number: I.1)
Place of text to be modified: Name and addresses
Instead of:
Read:
VII.2)Other additional information: